Restricted accessResearch articleFirst published online 2025-11
Assessing the effects of aging on the Koizumi’s and Zea Longa’s methods and their suitability as mouse models for evaluating neurodegeneration post-ischemic stroke: A comparative study
Koizumi’s and Zea Longa’s middle cerebral artery occlusion (MCAO) models (KMCAO and LMCAO) are commonly used methods in rodent ischemic stroke research. A key distinction between them lies in whether the blood flow through the common carotid artery (CCA) is maintained. Limited evidence exists regarding the systematic comparison of their pathophysiological characteristics, particularly considering the age of experimental mice. In this study, cerebral infarction outcomes were analyzed in mice aged 3, 6, 9, and 12 months. Mice aged 3–6 months exhibited minor cerebral infarction with KMCAO but substantial infarction with LMCAO, whereas differences diminished in 9–12-month-old mice. Comparable infarct severity in 3-month-old mice was achieved by inducing ischemia for 1.5 hours using KMCAO and for 1 hour using LMCAO, suggesting potential mechanistic similarities, subject to further research. LMCAO led to reperfusion injury due to preserved CCA perfusion, whereas KMCAO provided controlled ischemic insult via continuous CCA ligation. Both models confirmed that increased brain damage correlated with decreased neuronal nuclei expression and increased glial fibrillary acidic protein expression. These findings highlight the importance of selecting the MCAO model based on experimental objectives, age, and ischemia duration for the accurate modeling of ischemic and degenerative brain injury.
MozaffarianDBenjaminEJGoAS, et al.
Heart disease and stroke statistics–2015 update: a report from the American heart association. Circulation2015;
131: 29.
2.
MurrayCJLVosTLozanoR, et al.
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet2012;
380: 2197–2223.
3.
LiptonP.Ischemic cell death in brain neurons. Physiol Rev1999;
79: 1431–1568.
4.
VermaMLizamaBNChuCT.Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener2022;
11: 3–7.
BrunelliSGiannellaEBizzagliaM, et al.
Secondary neurodegeneration following stroke: what can blood biomarkers tell us?Front Neurol2023;
14: 1198216.
7.
BéjotYYaffeK.Ageing population: a neurological challenge. Neuroepidemiology2019;
52: 76–77.
8.
BéjotYBaillyHGraberM, et al.
Impact of the ageing population on the burden of stroke: the Dijon stroke registry. Neuroepidemiology2019;
52: 78–85.
9.
LiuFMcCulloughLD.Interactions between age, sex, and hormones in experimental ischemic stroke. Neurochem Int2012;
61: 1255–1265.
10.
FingerCEMoreno-GonzalezIGutierrezA, et al.
Age-related immune alterations and cerebrovascular inflammation. Mol Psychiatry2022;
27: 803–818.
11.
Roy-O’ReillyMAAhnstedtHSpychalaMS, et al.
Aging exacerbates neutrophil pathogenicity in ischemic stroke. Aging (Albany NY)2020;
12: 436–461.
12.
GallegoIVillate-BeitiaISaenz-Del-BurgoL, et al.
Therapeutic opportunities and delivery strategies for brain revascularization in stroke, neurodegeneration, and aging. Pharmacol Rev2022;
74: 439–461.
13.
KoizumiJ-iYoshidaYNakazawaT, et al.
Experimental studies of ischemic brain edema. I. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke1986;
8: 1–8.
14.
LongaEZWeinsteinPRCarlsonS, et al.
Reversible Middle cerebral artery occlusion without craniectomy in rats. Stroke1989;
20: 84–91.
15.
SmithHKRussellJMGrangerDN, et al.
Critical differences between two classical surgical approaches for middle cerebral artery occlusion-induced stroke in mice. J Neurosci Methods2015;
249: 99–105.
16.
FanJLiYFuX, et al.
Nonhuman primate models of focal cerebral ischemia. Neural Regen Res2017;
12: 321–328.
17.
FluriFSchuhmannMKKleinschnitzC.Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther2015;
9: 3445–3454.
18.
LiuSZhenGMeloniBP, et al.
Rodent stroke model guidelines for preclinical stroke trials. (1st Edition). J Exp Stroke Transl Med2009;
2: 2–27.
19.
SchaarKLBrennemanMMSavitzSI.Functional assessments in the rodent stroke model. Exp Transl Stroke Med2010;
2: 13–13.
20.
RenCSyCGaoJ, et al.
Animal stroke model: ischemia-reperfusion and intracerebral hemorrhage. Methods Mol Biol2016;
1462: 373–390.
21.
MacraeIM.Preclinical stroke research–advantages and disadvantages of the most common rodent models of focal ischaemia. Br J Pharmacol2011;
164: 1062–1078.
22.
SchallerBGrafR.Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab2004;
24: 351–371.
23.
WardlawJMMurrayVBergeE, et al.
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet2012;
379: 2364–2372.
24.
HeitkampCWinkelmeierLHeitJJ, et al.
The negative effect of aging on cerebral venous outflow in acute ischemic stroke. J Cereb Blood Flow Metab2023;
43: 1648–1655.
25.
PeirettiPGMedanaCVisentinS, et al.
Determination of carnosine, anserine, homocarnosine, pentosidine and thiobarbituric acid reactive substances contents in meat from different animal species. Food Chem2011;
126: 1939–1947.
26.
HossainMFKharelMHusnaAU, et al.
Prevalence of electrolyte imbalance in patients with acute stroke: a systematic review. Cureus2023;
15: e43149.
27.
Martí-FàbregasJGomisMArboixA, et al.
Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke2004;
35: 1117–1121.
28.
HessASHessJR.Linear regression and correlation. Transfusion2017;
57: 9–11.
29.
AltmanNKrzywinskiM.Simple linear regression. Nat Methods2015;
12: 999–1000.
30.
IsmaelSZhaoLNasoohiS, et al.
Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep2018;
8: 5971–x.
31.
SuSHWuYFLinQ, et al.
URB597 protects against NLRP3 inflammasome activation by inhibiting autophagy dysfunction in a rat model of chronic cerebral hypoperfusion. J Neuroinflammation2019;
16: 260.
32.
AlishahiMFarzanehMGhaedrahmatiF, et al.
NLRP3 inflammasome in ischemic stroke: as possible therapeutic target. Int J Stroke2019;
14: 574–591.
33.
ClarkRKLeeEVWhiteRF, et al.
Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull1994;
35: 387–392.
34.
GarnierPDemougeotCBertrandN, et al.
Stress response to hypoxia in gerbil brain: HO-1 and Mn SOD expression and glial activation. Brain Res2001;
893: 301–309.
35.
Muñoz-MancoJIGutiérrez-VargasJACardona-GómezGP.Neurogenesis and gliogenesis modulation in cerebral ischemia by CDK5 RNAi-based therapy. Biomedica2018;
38: 388–397.
36.
GuoZSuYLouH.GFAP-positive progenitor cell production is concentrated in specific encephalic regions in young adult mice. Neurosci Bull2018;
34: 769–778.
37.
FukuyamaRIzumotoTFushikiS.The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer’s disease patients and correlates with severity of dementia. Eur Neurol2001;
46: 35–38.
38.
TuoQLiuyangZLeiP, et al.
Zinc induces CDK5 activation and neuronal death through CDK5-Tyr15 phosphorylation in ischemic stroke. Cell Death Dis2018;
9: 870.
39.
MennBBachSBlevinsTL, et al.
Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. PLoS One2010;
5: e12117.
40.
MeyerDATorres-AltoroMITanZ, et al.
Ischemic stroke injury is mediated by aberrant Cdk5. J Neurosci2014;
34: 8259–8267.
41.
ZhuYLiuFZouX, et al.
Comparison of unbiased estimation of neuronal number in the rat hippocampus with different staining methods. J Neurosci Methods2015;
254: 73–79.
42.
ZhangJBaraschNLiR, et al.
Inhibition of cytosolic phospholipase A2 alpha protects against focal ischemic brain damage in mice. Brain Res2012;
1471: 129–137.
43.
MorrisGPWrightALTanRP, et al.
A comparative study of variables influencing ischemic injury in the Longa and Koizumi methods of intraluminal filament Middle cerebral artery occlusion in mice. PLoS One2016;
11: e0148503.
44.
LiYTanLYangC, et al.
Distinctions between the koizumi and zea longa methods for Middle cerebral artery occlusion (MCAO) model: a systematic review and meta-analysis of rodent data. Sci Rep2023;
13: 10247–w.
45.
TüreyenKVemugantiRSailorKA, et al.
Ideal suture diameter is critical for consistent middle cerebral artery occlusion in mice. Neurosurgery2005;
56: 196–200.
46.
HuXBaoYLiM, et al.
The role of ferroptosis and its mechanism in ischemic stroke. Exp Neurol2024;
372: 114630.
47.
HanYLiuXJinM, et al.
Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases. Inflamm Res2023;
72: 1839–1859.
48.
YuPZhangXLiuN, et al.
Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther2021;
6: 128.
49.
CollRCSchroderKPelegrínP.NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci2022;
43: 653–668.
50.
DuttaSSenguptaP.Men and mice: relating their ages. Life Sci2016;
152: 244–248.
51.
De MoudtSHendrickxJONeutelC, et al.
Progressive aortic stiffness in aging C57Bl/6 mice displays altered contractile behaviour and extracellular matrix changes. Commun Biol2022;
5: 605–x.
52.
ShvedovaMIslamMRArmoundasAA, et al.
Modified Middle cerebral artery occlusion model provides detailed intraoperative cerebral blood flow registration and improves neurobehavioral evaluation. J Neurosci Methods2021;
358: 109179.
53.
RhaJSaverJL.The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke2007;
38: 967–973.
54.
MolinaCAAlvarez-SabínJ.Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis2009;
27 Suppl 1: 162–167.
55.
HafeezFRazzaqMALevineRL, et al.
Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis2007;
16: 273–277.
56.
GibsonCLAttwoodL.The impact of gender on stroke pathology and treatment. Neurosci Biobehav Rev2016;
67: 119–124.
57.
RexrodeKMMadsenTEYuAXY, et al.
The impact of sex and gender on stroke. Circ Res2022;
130: 512–528.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
